Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitors.
Burns, Timothy F
Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitors. [electronic resource] - Oncology (Williston Park, N.Y.) Jan 2010 - 48-9 p. digital
Publication Type: Journal Article; Review; Comment
0890-9091
Antineoplastic Agents--therapeutic use
Clinical Trials as Topic
Enzyme Inhibitors--therapeutic use
ErbB Receptors--genetics
Humans
Lung Neoplasms--drug therapy
Mutation
Protein-Tyrosine Kinases--antagonists & inhibitors
Smoking--adverse effects
Lung cancer in 'never-smokers': beyond EGFR mutations and EGFR-TK inhibitors. [electronic resource] - Oncology (Williston Park, N.Y.) Jan 2010 - 48-9 p. digital
Publication Type: Journal Article; Review; Comment
0890-9091
Antineoplastic Agents--therapeutic use
Clinical Trials as Topic
Enzyme Inhibitors--therapeutic use
ErbB Receptors--genetics
Humans
Lung Neoplasms--drug therapy
Mutation
Protein-Tyrosine Kinases--antagonists & inhibitors
Smoking--adverse effects